Blood Flow and Tumour-Induced Angiogenesis: Dynamically Adapting Vascular Networks

  • Mark A. J. Chaplain
  • Steven R. McDougall
  • Alexander R. A. Anderson


Over the past decade or so, there has been a large number of modeling approaches aimed at elucidating the most important mechanisms affecting the formation of new capillaries from parent blood vessels (angiogenesis). Most studies have focussed upon the way in which capillary sprouts are initiated and migrate in response to diffusible chemical stimuli supplied by hypoxic stromal cells and leukocytes in the contexts of solid tumour growth and wound healing. However, relatively few studies have examined the important role played by blood perfusion during angiogenesis and fewer still have explored the ways in which a dynamically evolving bed architecture can affect the distribution of flow within it. From the perspective of solid tumour growth and, perhaps more importantly, its subsequent treatment, it would clearly be of some benefit to understand this coupling between vascular structure and perfusion more fully. This chapter describes a hybrid model of vascular network formation coupled with flow and then focuses on the implications of such a coupling upon chemotherapeutic, anti-angiogenic, and anti-vascular treatments.


Wall Shear Stress Parent Vessel Endothelial Cell Density Matrix Degrading Enzyme Intravascular Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



MAJC and SMcD gratefully acknowledge the support of BBSRC Grant BBF0022541 “Guidance cues and pattern prediction in the developing retinal vasculature: a combined experimental and theoretical modeling approach”.


  1. Alarcon T, Byrne HM, Maini PK (2003) A cellular automaton model for tumour growth in inhomogeneous environment. J. Theor. Biol. 225(2), 257–274.PubMedCrossRefGoogle Scholar
  2. Anderson ARA, Chaplain MAJ (1998) Continuous and discrete mathematical models of tumor-induced angiogenesis. Bull. Math. Biol. 60, 857–899.PubMedCrossRefGoogle Scholar
  3. Armulik A, Abramsson A, Betsholtz C (2005) Endothelial/pericyte interactions. Circulation Research, 97, 512–523.PubMedCrossRefGoogle Scholar
  4. Ausprunk DH, Folkman J (1977) Migration and proliferationof endothelial cells in preformed and newly formed blood vessels during tumour angiogenesis. Microvasc. Res. 14, 53–65.PubMedCrossRefGoogle Scholar
  5. Bagley RG, et al. (2006) Pericytes from human non-small cell lung carcinomas: An attractive target for anti-angiogenic therapy. Microvascular Res. 71, 163–174.CrossRefGoogle Scholar
  6. Baish JW, Gazit Y, Berk DA, Nozue M, Baxter LT, Jain RK (1996) Role of tumor vascular architecture in nutrient and drug delivery: an invasion percolation-based network model. Microvasc. Res. 51, 327–346.PubMedCrossRefGoogle Scholar
  7. Benjamin LE, I. Hemo I, Keshet E (1998) A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125, 1591–1598.Google Scholar
  8. Bray D (1992) Cell Movements, New-York: Garland Publishing.Google Scholar
  9. Brekken RA, Thorpe PE (2001) Vascular endothelial growth factor and vascular targeting of solid tumors. 21, 4221–4229.Google Scholar
  10. Chantrain CF, Henriet P, Jodele S, Emonard H, Feron O, Courtoy PJ, DeClerck YA, Marbaix E (2006) Mecanisms of pericyte recruitment in tumour angiogenesis: A new role for metalloproteinases. European J. Cancer 42, 310–318.CrossRefGoogle Scholar
  11. Davis GE, Pintar Allen KA, Salazar R, Maxwell SA (2000) Matrix metalloproteinase-1 and –9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices. J. Cell Sci. 114, 917–930.Google Scholar
  12. El-Kareh AW, Secomb TW (1997) Theoretical models for drug delivery to solid tumours. Crit. Rev. Biomed. Eng. 25(6), 503–571.PubMedGoogle Scholar
  13. Folkman J, Klagsbrun M (1987) Angiogenic factors. Science. 235, 442–447.PubMedCrossRefGoogle Scholar
  14. Gee MS, Procopio WN, Makonnen S, Feldman MD, Yeilding NW, Lee WMF (2003) Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy. Am. J. Path. 162, 1, 183–193.PubMedCrossRefGoogle Scholar
  15. Gödde R, Kurz H (2001) Structural and biophysical simulation of angiogenesis and vascular remodelling. Developmental Dynamics 220, 387–401.PubMedCrossRefGoogle Scholar
  16. Hidalgo M, Eckhardt SG (2001) Development of matrix metalloproteinase inhibitors in cancer therapy. Journal of the National Cancer Institute 93, 178–193.PubMedCrossRefGoogle Scholar
  17. Hughes S, Gardiner T, Hu P, Baxter L, Rosinova E, Chan-Ling T (2006) Altered pericyte-endothelial relations in the rat retina during aging: Implications for vessel stability. Neurobiology of Aging 27, 1838–1847.PubMedCrossRefGoogle Scholar
  18. Izumi Y et al. (2002) Tumour biology: herceptin acts as an antiangiogenic cocktail. Nature 416, 279–280.PubMedCrossRefGoogle Scholar
  19. Jackson TL, Lubkin SR, Murray JD (1999) Theoretical analysis of conjugate localization in two-step cancer chemotherapy. J. Math. Biol. 39, 353–376.PubMedCrossRefGoogle Scholar
  20. Jain RK (2003) Molecular regulation of vessel maturation. Nat. Med. 9, 685–93.PubMedCrossRefGoogle Scholar
  21. Krenz GS, Dawson CA (2002) Vessel distensibility and flow distribution in vascular trees. J. Math. Biol. 44, 360–374.PubMedCrossRefGoogle Scholar
  22. Kumar CC (2000). Targeting integrins avb3 and avb5 for blocking tumour-induced angiogenesis. Adv. Exp. Med. Biol. 476, 169–180.PubMedCrossRefGoogle Scholar
  23. Levine HA, Pamuk S, Sleeman BD, Nielsen-Hamilton M (2001) Mathematical modeling of the capillary formation and development in tumor angiogenesis: penetration into the stroma. Bull. Math. Biol. 63(5), 801–863.PubMedCrossRefGoogle Scholar
  24. McDougall SR, Anderson ARA, Chaplain MAJ, and Sherratt JA (2002) Mathematical modeling of flow through vascular networks: implications for tumour-induced angiogenesis and chemotherapy strategies. Bull. Math. Biol. 64(4), 673–702.PubMedCrossRefGoogle Scholar
  25. McDougall SR, Anderson ARA, Chaplain MAJ (2006) Mathematical modeling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies. Journal of Theoretical Biology 241, 564–589.PubMedCrossRefGoogle Scholar
  26. Madri JA, Pratt BM (1986) Endothelial cell-matrix interactions: in vitro models of angiogenesis. J. Histochem. Cytochem. 34, 85–91.PubMedCrossRefGoogle Scholar
  27. Mancuso MR, et al. (2006) Rapid vascular regrowth in tumors after reversal of VEGF inhibition. J. Clin. Investigation. 116, (10), 2610–2621.CrossRefGoogle Scholar
  28. Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK, McDonald DM (2002) Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am. J. Path. 160, 985–1000.PubMedCrossRefGoogle Scholar
  29. Munn LL (2003) Aberrant vascular architecture in tumors and its importance in drug-based therapies. Drug Discovery Today 8, 396–403.PubMedCrossRefGoogle Scholar
  30. Paweletz N, Knierim M (1989) Tumor-related angiogenesis. Crit. Rev. Oncol. Hematol. 9, 197–242.PubMedCrossRefGoogle Scholar
  31. Pries AR, Secomb TW, Gaehtgens P (1996) Biophysical aspects of blood flow in the microvasculature. Cardiovasc Res, 32, 654–667.PubMedGoogle Scholar
  32. Pries AR, Secomb TW, Gaehtgens P (1998) Structural adaptation and stability of microvascular netwoks: theory and simulation. Am. J. Physiol. 275 (Heart Circ. Physiol. 44), H349–H360.Google Scholar
  33. Pries AR, Reglin B, Secomb TW (2001a) Structural adaptation of microvascular networks: functional roles of adaptive responses. Am. J. Physiol. Heart Circ. Physiol. 281, H1015–H1025.PubMedGoogle Scholar
  34. Pries AR, Reglin B, Secomb TW (2001b) Structural adaptation of vascular networks: role of the pressure response. Hypertension 38, 1476–1479.PubMedCrossRefGoogle Scholar
  35. Quarteroni A, Tuveri M, Veneziani A (2000) Computational vascular fluid dynamics: problems, models and methods. Comput. Visual. Sci. 2, 163–197.CrossRefGoogle Scholar
  36. Rafil S, et al. (2002) Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nature Reviews Cancer 2, 826–835.CrossRefGoogle Scholar
  37. Rouget C (1873) Memoire sur le developpement, la structure et les proprietes physiologiques des capillaires sanguins et lymphatiques. Arch. Physiol. Norm. Pathol. 5: 603–663.Google Scholar
  38. Secomb TW (1995) Mechanics of blood flow in the microcirculation. In “Biological Fluid Dynamics.” eds. C.P. Ellington and T.J. Pedley. Company of Biologists, Cambridge, pp. 305–321.Google Scholar
  39. Schoefl GI (1963) Studies of inflammation III. Growing capillaries: Their structure and permeability. Virchows Arch. Path. Anat. 337, 97–141.Google Scholar
  40. Sholley MM, Ferguson GP, Seibel HR, Montour JL, Wilson JD (1984) Mechanisms of neovascularization. Vascular sprouting can occur without proliferation of endothelial cells. Lab. Invest. 51, 624–634.Google Scholar
  41. Stéphanou A, McDougall SR, Anderson ARA, Chaplain MAJ (2005a) Mathematical modeling of flow in 2D and 3D vascular networks: applications to anti-angiogenic and chemotherapeutic drug strategies. Math. Comp. Model. 41, 1137–1156.CrossRefGoogle Scholar
  42. Stéphanou A, McDougall SR, Anderson ARA, Chaplain (2005b) Mathematical modeling of the influence of blood rheological properties upon adaptive tumour-induced angiogenesis. Math. Comp. Model. 44, 96–123.Google Scholar
  43. Sternlicht MD, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17, 463–516.PubMedCrossRefGoogle Scholar
  44. Tozer GM, Kanthou C, Baguley BC (2005) Disrupting tumour blood vessels. Nature Reviews Cancer Vol 5 (June 2005), 423–433.CrossRefGoogle Scholar
  45. Yan L, Moses MA, Huang S, Ingber D (2000) Adhesion-dependent control of matrix metalloproteinase-2 activation in human capillary endothelial cells. J. Cell Sci. 113, 3979–3987.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Mark A. J. Chaplain
    • 1
  • Steven R. McDougall
    • 2
  • Alexander R. A. Anderson
    • 3
  1. 1.University of DundeeDundeeScotland
  2. 2.Heriot-Watt UniversityEdinburghScotland
  3. 3.H. Lee Moffitt Cancer Center and Research InstituteFLUSA

Personalised recommendations